Viracta Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viracta Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Viracta Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -680 %, a 554% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2023 was -146 %, a 116% decline from 2022.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2022 was -67.5 %, a 35.3% increase from 2021.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2021 was -104 %, a 315% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -146 -78.2 -116% Jan 1, 2023 Dec 31, 2023
2022 -67.5 +36.8 +35.3% Jan 1, 2022 Dec 31, 2022
2021 -104 -153 -315% Jan 1, 2021 Dec 31, 2021
2020 48.6 +214 Jan 1, 2020 Dec 31, 2020
2019 -166 +401 +70.8% Jan 1, 2019 Dec 31, 2019
2018 -567 -290 -105% Jan 1, 2018 Dec 31, 2018
2017 -277 +12.6 +4.34% Jan 1, 2017 Dec 31, 2017
2016 -289 -89.6 -44.8% Jan 1, 2016 Dec 31, 2016
2015 -200 +91.6 +31.4% Jan 1, 2015 Dec 31, 2015
2014 -291 -1.12K -135% Jan 1, 2014 Dec 31, 2014
2013 832 +1.23K Jan 1, 2013 Dec 31, 2013
2012 -402 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.